Odyssean LLC’s Apellis Pharmaceuticals APLS Stock Holding History

Odyssean LLC’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-31,032	Closed	-$1.25M	–	490
2026 Q1	$1.25M	Buy	31,032 +11,825	+62%	+$255K	0.46%	84
2025 Q4	$482K	Buy	+19,207	New	+$451K	0.35%	162

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Odyssean LLC's APLS Position: Q2 2026 in Review

Odyssean LLC sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 31,032 shares — an estimated $1.25M sold.

Odyssean LLC first reported a position in APLS in Q4 2025 and held it in 2 quarters. The position peaked at $1.25M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Odyssean LLC reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Odyssean LLC sold 31,032 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.25M.
Odyssean LLC first reported a position in Apellis Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Odyssean LLC's Apellis Pharmaceuticals position peaked at $1.25M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.